Cross-Border Multi-Jurisdictional Regulatory Submission Sequencing Strategist

Global regulatory affairs leads at multinational pharmaceutical companies use this agent when planning the submission sequence and regulatory pathway for a new drug application across multiple jurisdictions simultaneously (FDA, EMA, PMDA, Health Canada, TGA), optimising for earliest market access while managing reference product dependency risks between agencies and resource constraints.